Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Total Current Liabilities (2020 - 2022)

Atea Pharmaceuticals (AVIR) has 3 years of Total Current Liabilities data on record, last reported at $15.6 million in Q3 2022.

  • For Q3 2022, Total Current Liabilities fell 94.03% year-over-year to $15.6 million; the TTM value through Sep 2022 reached $15.6 million, down 94.03%, while the annual FY2021 figure was $56.9 million, 81.99% down from the prior year.
  • Total Current Liabilities reached $15.6 million in Q3 2022 per AVIR's latest filing, down from $25.1 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $315.8 million in Q4 2020 and bottomed at $10.8 million in Q3 2020.
  • Average Total Current Liabilities over 3 years is $138.1 million, with a median of $56.9 million recorded in 2021.
  • Peak YoY movement for Total Current Liabilities: soared 2322.82% in 2021, then crashed 94.03% in 2022.
  • A 3-year view of Total Current Liabilities shows it stood at $315.8 million in 2020, then tumbled by 81.99% to $56.9 million in 2021, then plummeted by 72.52% to $15.6 million in 2022.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $15.6 million in Q3 2022, $25.1 million in Q2 2022, and $28.6 million in Q1 2022.